IDXX Q4 2021 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$801M+11.1% YoY

Gross Profit

$456M57.0% margin

Operating Income

$199M24.9% margin

Net Income

$163M20.3% margin

EPS (Diluted)

$1.89

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$210M

Free Cash Flow

$178M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.7B

Stockholders' Equity

$690M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$801M	$721M	+11.1%
Gross Profit	$456M	$410M	+11.5%
Operating Income	$199M	$185M	+7.6%
Net Income	$163M	$175M	-6.9%

Revenue Segments

Instrument Rebate Programs

$3M100%

Geographic Segments

UNITED STATES

$493M55%

Asia Pacific

$174M20%

EMEA

$171M19%

CANADA

$34M4%

Latin America

$18M2%